Related Experiment Video
Updated: Oct 20, 2025
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
13.1K
Corrigendum: Polypharmacy to Mitigate Acute and Delayed Radiation Syndromes
Tracy Gasperetti1, Tessa Miller1, Feng Gao1
1Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, United States.
Frontiers in Pharmacology
|September 13, 2021
Summary
This study corrects a previous article DOI. The corrected DOI is 10.3389/fphar.2021.634477, ensuring accurate citation and retrieval of scientific information.
Area of Science:
- Pharmacology and Toxicology
- Scientific Publishing
Context:
- Correction of a previously published article's Digital Object Identifier (DOI).
- Ensuring accurate referencing in scientific literature.
Purpose:
- To provide the correct DOI for the article.
- To facilitate proper citation and access to the research.
Summary:
- The Digital Object Identifier (DOI) for the article 10.3389/fphar.2021.634477 has been corrected.
- This ensures that readers and indexing services can accurately locate and cite the publication.
Impact:
- Improved discoverability and accessibility of the scientific article.
- Maintained integrity and accuracy of scientific records and citations.
Related Concept Videos
01:28Drug Therapy
119
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
119
01:24Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
36
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
36
01:15Drug Dosing: Geriatric Patients
34
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
34
01:15Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
169
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
169
01:01Dosage Regimens: Partial Pharmacokinetic Parameters
28
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
28
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
24
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
24